throbber
MAI MOTOMONTANT LITHUTUON TUIN
`
`US009925231B2
`
`( 12 ) United States Patent
`Comiskey et al .
`
`( 10 ) Patent No . :
`( 45 ) Date of Patent :
`
`US 9 , 925 , 231 B2
`* Mar . 27 , 2018
`
`( 72 )
`
`( 54 ) FORMULATIONS OF GUANYLATE
`CYCLASE C AGONISTS AND METHODS OF
`USE
`( 71 ) Applicant : SYNERGY PHARMACEUTICALS ,
`INC . , New York , NY ( US )
`Inventors : Stephen Comiskey , Doylestown , PA
`( US ) ; Rong Feng , Langhorne , PA ( US ) ;
`John Foss , Doylestown , PA ( US ) ;
`Kunwar Shailubhai , Audubon , PA
`( US )
`( 73 ) Assignee : SYNERGY PHARMACEUTICALS ,
`INC . , New York , NY ( US )
`Subject to any disclaimer , the term of this
`patent is extended or adjusted under 35
`U . S . C . 154 ( b ) by 0 days .
`This patent is subject to a terminal dis
`claimer .
`( 21 ) Appl . No . : 15 / 467 , 631
`( 22 ) Filed :
`Mar . 23 , 2017
`Prior Publication Data
`( 65 )
`US 2017 / 0202903 A1
`Jul . 20 , 2017
`
`( * ) Notice :
`
`Related U . S . Application Data
`( 63 ) Continuation of application No . 14 / 845 , 644 , filed on
`Sep . 4 , 2015 , now Pat . No . 9 , 610 , 321 , which is a
`continuation of application No . 14 / 661 , 299 , filed on
`Mar . 18 , 2015 , now abandoned , which is
`a
`continuation of application No . 13 / 421 , 769 , filed on
`Mar . 15 , 2012 , now Pat . No . 9 , 616 , 097 , which is a
`continuation - in - part of application No . PCT /
`US2011 / 051805 , filed on Sep . 15 , 2011 .
`
`( 60 )
`
`( 51 )
`
`( 52 )
`
`( 58 )
`
`Provisional application No . 61 / 392 , 186 , filed on Oct .
`12 , 2010 , provisional application No . 61 / 387 , 636 ,
`filed on Sep . 29 , 2010 , provisional application No .
`61 / 383 , 156 , filed on Sep . 15 , 2010 .
`Int . Ci .
`A61K 38 / 10
`A61K 47 / 12
`A61K 4738
`A61K 9 / 16
`A61K 45 / 06
`A61K 9 / 48
`CO7K 7 / 08
`CO7K 7 / 64
`U . S . CI .
`??? . . . . . . . . . . A61K 38 / 10 ( 2013 . 01 ) ; A61K 9 / 1623
`( 2013 . 01 ) ; A61K 9 / 1652 ( 2013 . 01 ) ; A61K
`9 / 1676 ( 2013 . 01 ) ; A61K 9 / 4858 ( 2013 . 01 ) ;
`A61K 9 / 4866 ( 2013 . 01 ) ; A61K 45 / 06
`( 2013 . 01 ) ; A61K 47 / 12 ( 2013 . 01 ) ; A61K 47 / 38
`( 2013 . 01 ) ; CO7K 7 / 08 ( 2013 . 01 ) ; CO7K 7 / 64
`( 2013 . 01 )
`
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`( 2006 . 01 )
`
`Field of Classification Search
`None
`See application file for complete search history .
`
`( 56 )
`
`References Cited
`U . S . PATENT DOCUMENTS
`5 , 106 , 834 A
`4 / 1992 Bovy et al .
`5 , 130 , 333 A
`7 / 1992 Pan et al .
`5 , 489 , 670 A
`2 / 1996 Currie et al .
`5 , 518 , 888 A
`5 / 1996 Waldman et al .
`5 , 578 , 709 A
`11 / 1996 Woiszwillo et al .
`5 , 601 , 990 A
`2 / 1997 Waldman et al .
`5 , 721 , 238 A
`2 / 1998 Heiker et al .
`5 , 731 , 159 A
`3 / 1998 Waldman et al .
`5 , 817 , 624 A
`10 / 1998 Yang et al .
`5 , 879 , 656 A
`3 / 1999 Waldman et al .
`5 , 928 , 873 A
`7 / 1999 Waldman et al .
`5 , 969 , 097 A
`10 / 1999 Wiegand et al .
`6 , 060 , 037 A
`5 / 2000 Waldman et al .
`6 , 235 , 782 B1
`5 / 2001 Pamukcu et al .
`7 , 041 , 786 B2
`5 / 2006 Shailubhai et al .
`7 , 067 , 748 B1
`7 / 2006 Whitmore , Jr . et al .
`7 , 375 , 083 B2
`5 / 2008 Mickle et al .
`7 , 494 , 979 B2
`2 / 2009 Currie et al .
`7 , 799 , 897 B2
`9 / 2010 Jacob et al .
`7 , 879 , 802 B2
`2 / 2011 Shailubhai et al .
`8 , 034 , 782 B2
`10 / 2011 Shailubhai
`8 , 114 , 831 B2
`2 / 2012 Shailubhai et al .
`8 , 207 , 295 B2
`6 / 2012 Shailubhai et al .
`8 , 357 , 775 B2
`1 / 2013 Shailubhai et al .
`8 , 367 , 800 B2
`2 / 2013 Shailubhai
`8 , 497 , 348 B2
`7 / 2013 Shailubhai et al .
`8 , 569 , 246 B2
`10 / 2013 Shailubhai
`8 , 637 , 451 B2
`1 / 2014 Shailubhai et al .
`8 , 664 , 354 B2
`3 / 2014 Shailubhai
`8 , 716 , 224 B2
`5 / 2014 Shailubhai et al .
`8 , 901 , 075 B2 12 / 2014 Shailubhai et al .
`8 , 969 , 514 B2
`3 / 2015 Shailubhai
`9 , 238 , 677 B21 / 2016 Shailubhai et al .
`9 , 266 , 926 B2
`2 / 2016 Shailubhai et al .
`9 , 486 , 494 B2 11 / 2016 Shailubhai
`9 , 545 , 446 B2
`1 / 2017 Riff et al .
`9 , 610 , 321 B2 *
`4 / 2017 Comiskey . . . . . . . . . . . . A61K 9 / 1623
`9 , 616 , 097 B2 *
`4 / 2017 Comiskey . . . . . . . . . . . . A61K 9 / 1623
`( Continued )
`FOREIGN PATENT DOCUMENTS
`2009 - 519343 A
`5 / 2009
`2009 - 537535 A
`10 / 2009
`( Continued )
`OTHER PUBLICATIONS
`Shailubhai et al . , “ A randomized , double - blind , u placebo - con
`trolled , single - , ascending - , oral - dose safety , tolerability and
`pharmacokinetic study of SP - 304 in healthy adult human male and
`female volunteers . ” Digestive Disease Week . San Diego : 2008 . *
`( Continued )
`Primary Examiner — Satyanarayana R Gudibande
`Assistant Examiner — Jia - Hai Lee
`( 74 ) Attorney , Agent , or Firm — Cynthia A . Kozakiewicz ;
`Ivor Elrifi
`ABSTRACT
`( 57 )
`The invention provides low - dose formulations of guanylate
`cyclase - C ( “ GCC ” ) agonist peptides and methods for their
`use . The formulations of the invention can be administered
`either alone or in combination with one or more additional
`therapeutic agents , preferably an inhibitor of cGMP - depen
`dent phosphodiesterase or a laxative .
`12 Claims , 6 Drawing Sheets
`
`MYLAN - EXHIBIT 1001
`
`

`

`US 9 , 925 , 231 B2
`Page 2
`
`( 56 )
`
`References Cited
`U . S . PATENT DOCUMENTS
`2002 / 0128176 AL 9 / 2002 Forssmann et al .
`2002 / 0133168 A19 / 2002 Smeldley et al .
`2002 / 0143015 Al 10 / 2002 Fryburg et al .
`2003 / 0073628 A14 / 2003 Shailubhai et al .
`2004 / 0015140 A1
`1 / 2004 Shields
`2005 / 0016244 AL
`1 / 2005 Hergemoller
`2005 / 0032684 Al
`2 / 2005 Cetin et al .
`2005 / 0107734 AL
`5 / 2005 Coroneo
`2005 / 0145351 A1
`7 / 2005 Schaible et al .
`2005 / 0266047 Al 12 / 2005 Tu et al .
`2005 / 0267297 A
`12 / 2005 Berlin
`2006 / 0086653 Al
`4 / 2006 St . Germain
`2006 / 0094658 A1
`5 / 2006 Currie
`2007 / 0101158 Al 5 / 2007 Elliott
`2008 / 0137318 Al
`6 / 2008 Rangaraj et al .
`2008 / 0151257 Al 6 / 2008 Yasuda et al .
`2009 / 0048175 Al 2 / 2009 Shailubhai et al .
`2009 / 0192083 A1
`7 / 2009 Currie
`2009 / 0253634 Al 10 / 2009 Currie et al .
`2010 / 0048489 Al
`2 / 2010 Fretzen
`2010 / 0069306 Al
`3 / 2010 Shailubhai et al .
`2010 / 0093635 A1 4 / 2010 Shailubhai
`2010 / 0120694 Al 5 / 2010 Shailubhai et al .
`2010 / 0152118 Al 6 / 2010 Shailubhai
`2010 / 0221329 Al
`9 / 2010 Shailubhai et al .
`2012 / 0196797 A18 / 2012 Currie et al .
`2012 / 0237593 AL
`9 / 2012 Comiskey et al .
`2012 / 0289460 AL 11 / 2012 Shailubhai
`2013 / 0274204 Al 10 / 2013 Shailubhai et al .
`2014 / 0024605 AL
`1 / 2014 Shailubhai et al .
`2014 / 0121169 Al
`5 / 2014 Shailubhai et al .
`2014 / 0135274 AL
`5 / 2014 Shailubhai
`2014 / 0187470 A1
`7 / 2014 Jacob et al .
`2014 / 0287002 A19 / 2014 Shailubhai
`2014 / 0329738 A1 11 / 2014 Shailubhai et al .
`2015 / 0359749 Al 12 / 2015 Shailubhai et al .
`2015 / 0366935 Al 12 / 2015 Comiskey et al .
`2016 / 0367623 Al 12 / 2016 Shailubhai
`2017 / 0202904 A1 7 / 2017 Comiskey et al .
`FOREIGN PATENT DOCUMENTS
`2010 - 519217 A
`6 / 2010
`WO 1999 / 026567 A1 6 / 1999
`WO 2001 / 025266 A1
`4 / 2001
`WO 2002 / 062369 A2
`8 / 2002
`WO 2002 / 078683 Al 10 / 2002
`WO 2002 / 098912 A3 12 / 2002
`WO 2004 / 069165 A2
`8 / 2004
`WO2005016244 A1 *
`2 / 2005
`WO 2005 / 087797 A1 9 / 2005
`WO 2006 / 086653 A2
`8 / 2006
`WO 2007 / 022531 A2
`2 / 2007
`WO 2007 / 070562 A2
`6 / 2007
`WO 2007 / 101158 A2
`9 / 2007
`WO 2007 / 133796 A2 11 / 2007
`WO 2008 / 102264 A2
`8 / 2008
`WO 2008 / 106429 A2
`9 / 2008
`WO 2008 / 137318 Al 11 / 2008
`WO 2008 / 151257 A2 12 / 2008
`WO 2009 / 149278 Al 12 / 2009
`WO 2009 / 149279 A2 12 / 2009
`WO 2010 / 009319 A2
`1 / 2010
`WO 2010 / 027404 A2
`3 / 2010
`WO 2010 / 065751 A2
`6 / 2010
`WO 2011 / 020054 Al 2 / 2011
`WO 2012 / 037380 A2
`3 / 2012
`WO 2013 / 138352 AL
`9 / 2013
`
`JP
`WO
`WO
`WO
`WO
`WO
`W0
`WO
`WO
`WO
`WO
`wo
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`wo
`
`OTHER PUBLICATIONS
`Advisory Committee Briefing document for Merida ( sibutramine
`hydrochloride monohydrate ] , Abbott , Aug . 13 , 2010 ( 205 pages ) .
`
`Alrefai , “ Cholesterol modulates human intestinal sodium - depen
`dent bile acid transporter , " Am . J . Physiol . Gastrointest . Liver
`Physiol . 288 : G978 - G985 ( 2005 ) .
`Askling “ Colorectal cancer rates among first degree relatives of
`patients with inflammatory bowel disease : A population - based
`cohort study ” Lancet 357 : 262 - 266 ( 2001 ) .
`Bakre et al . “ Expression and regulation of the cGMP - binding ,
`CGMP - specific phosphodiesterase ( PDE5 ) in human colonic epi
`thelial cells : role in the induction of cellular refractoriness to the
`heat - stable enterotoxin peptide " J . Cell Biol . 77 : 159 - 167 ( 2000 ) .
`Barbara “ A role for inflammation in irritable bowel syndrome ” : Gut ,
`51 ( Suppl . 1 ) : 141 - 144 ( 2002 ) .
`Basoglu In : Proceedings of the Second Feps Congress , Jun . 29 - Jul .
`4 , 1999 , Prague , Czech Republic , If2 . cuni . cz / physiolres / feps /
`basoglu . htm . ( 3 pages ) .
`Baxter “ The natriuretic peptides : An introduction ” Basic Res .
`Cardiol . 99 ( 2 ) : 71 - 75 ( 2004 ) .
`Beltowski “ Guanlyin and related peptides ” J . Physiol . Pharmacol
`52 ( 3 ) : 351 - 375 ( 2001 ) .
`Bergers “ Extrinsic regulators of epithelial tumor progression : metal
`loproteinases " Cur . Opin . Gen . and Develop . 10 : 120 - 127 ( 2000 ) .
`Bhakdi “ Release of interleukin - 1 beta associated with potent
`cytocidal action of staphylococcal alpha - toxin on human
`monocytes ” Infect . Immun . 57 ( 11 ) : 3512 - 3519 ( 1989 ) .
`Brown “ A receptor - mediated pathway for cholesterol homeostasis ”
`Sci . 232 : 34 - 47 ( 1986 ) .
`Burnham “ Polymers for delivering peptides and proteins ” Am . J .
`Hosp . Pharm . 51 : 210 - 218 ( 1994 ) .
`Caliceti “ Synthesis and biopharmaceutical characterisation of new
`poly ( hydroxethylaspartamide ) copolymers as drug carriers ”
`Biochimica et Biophysics Acta 1528 : 177 - 189 ( 2001 ) .
`Camilleri “ Management of the irritable bowel syndrome ”
`Gastroentrerol . 120 : 652 - 668 ( 2001 ) .
`Carrithers , “ Guanylyl cyclase C is a selective marker for metastatic
`colorectal tumors in human extraintestinal tissues ” Proc . Natl . Acad .
`Sci . USA 93 : 14827 - 14832 . ( 1996 ) .
`Cermak “ Natriuretic peptides increase a K + conductance in rat
`mesangial cells ” Pfugers Arch . Eur . J . Physiol . 431 : 571 - 577 ( 1996 ) .
`Cheng “ Defective intracellular transport and processing of CFTR is
`the molecular basis of most cystic fibrosis ” Cell , 63 : 827 - 834 ( 1990 ) .
`Chino “ Topological isomers of human uroguanylin : interconversion
`between biologically active and inactive isomers ” FEBS Letters
`421 : 27 - 31 ( 1998 ) .
`Cohen “ Guanylin mRNA expression in human intestine and
`colorectal adenocarcinoma ” Lab . Invest . 78 : 101 - 108 ( 1998 ) .
`Collins “ The relationship of enteric microbial infection and func
`tional bowel disorders ” J . Clin . Gastroenterol 41 Suppl . 1 : S30 - 32
`( 2007 ) .
`Cui The permissive effect of zinc deficiency on uroguanylin and
`inducible nitric oxide synthase gene upregulation in rat intestine
`induced by interleukin la is rapidly reversed by zinc repletion . J .
`Nutri . 133 ( 1 ) : 51 - 56 ( 2003 ) .
`Currie , “ Guanylin : An endogenous activator of intestinal guanylate
`cyclase , " Proc . Natl . Acad . Sci . USA 89 : 947 - 951 ( 1992 ) .
`Database BIOSIS ( Online ) , biosciences Information Service , Phila
`delphia , PA , U . S . , Apr . 2006 , Refaat " SP304 , an analog of
`uroguanylin , ameliorates inflammation in a model of experimental
`colitis ”
`XP002540570 ,
`Database
`Accession
`No .
`PREV200600503788 , 2 pages .
`De Luca “ Inflammation and insulin resistance ” FEBS Letter
`582 : 97 - 105 ( 2008 ) .
`Delvaux “ Effect of alosetron on responses to colonic distension in
`patients with irritable bowel syndrome ” Aliment Pharmacol . Ther
`12 : 849 - 855 ( 1998 ) .
`Dennis “ Off by a whisker " Nature 442 : 739 - 741 ( 2006 ) .
`DeSAUVAGE " Precursor structure , expression and tissue distribu
`tion of human guanylin ” Proc . Natl . Acad . Sci USA 89 : 9089 - 9093
`( 1992 ) .
`Deschner “ Proliferative defects in ulcerative colitis patients ” Can .
`Invest 1 : 41 - 47 ( 1983 ) .
`Duncan “ Drug - polymer Conjugates : Potential for improved chemo
`therapy ” Anti - Can . Drugs 3 : 175 - 210 ( 1992 ) .
`
`

`

`US 9 , 925 , 231 B2
`Page 3
`
`( 56 )
`
`References Cited
`OTHER PUBLICATIONS
`Dunfield “ Energy parameters in polypeptides . 8 . Empirical potential
`energy algorithm for the conformational analysis of large mol
`ecules ” J . Phys . Chem . 82 : 2609 - 2616 ( 1978 ) .
`Eastwood “ Epithelial renewal in premalignant conditions of the
`gastrointestinal tract : A review ” J . Clin . Gastroenterol 14 ( 1 ) : S29
`S33 ( 1992 ) .
`Ettorre “ Mucosal changes in ileal pouches after restorative
`proctocolectomy for ulcerative and Crohn ' s colitis " Dis . Colon
`Rectum 43 : 1743 - 1748 ( 2000 ) .
`European Application No . 02721604 . 3 : Office Communication
`dated Aug . 12 , 2008 ( 3 pages ) .
`European Application No . 02721604 . 3 : Response to European
`Patent Office Communication dated Mar . 16 , 2007 ( 5 pages ) .
`European Patent 1 , 379 , 224 : CombiMab , Inc . Annex to Notice of
`Opposition dated Apr . 22 , 2010 ( 41 pages ) .
`European Patent 1 , 379 , 224 : Opposition dated Apr . 22 , 2010 ( 19
`pages ) .
`European Patent 1 , 379 , 224 : Response to Communication from
`Opposition division dated Oct . 8 , 2010 ( 44 pages ) .
`European Patent 1 , 379 , 224 : Written submission dated Dec . 7 , 2011
`( 6 pages )
`European Patent 1 , 379 , 224 : Written submission dated Nov . 18 , 2011
`by Ironwood ( 14 pages ) .
`European Patent 1 , 379 , 224 : Written submission dated Nov . 22 , 2011
`( 18 pages )
`European Patent 1 , 379 , 224 : Written submission dated Oct . 14 , 2011
`( 7 pages ) .
`European Patent 1 , 379 , 224 : Written submission dated Oct . 14 , 2011
`by Ironwood ( 27 pages ) .
`European Patent 1 , 379 , 224 : Written submission dated Oct . 25 ,
`2011 ( 5 pages ) .
`European Patent 1 , 379 , 224 : Written submission dated Oct . 7 , 2011
`in response to the Jun . 24 , 2011 preliminary opinion of the Oppo
`sition Division ( 7 pages ) .
`European Patent 1 , 379 , 224 : Summons to attend oral hearing dated
`Jun . 24 , 2011 ( 23 pages ) .
`European Patent Application No . 11825961 . 3 , Extended European
`Search Report dated Jun . 30 , 2016 , 6 pages .
`Evan “ Proliferation , cell cycle and apoptosis in cancer ” Nature
`( London ) 411 : 342 - 348 ( 2001 ) .
`Fan “ Structure and activity of uroguanylin and guanylin from the
`intestine and urine of rats ” Am . J . Physiol . Endocrinol . Metab .
`273 : 957 - 964 ( 1997 ) .
`Field , “ Ezetimibe interferes with cholesterol trafficking from the
`plasma membrane to the endoplasmic reticulum in CaCo - 2 cells , "
`Journal of Lipid Research , 48 : 1735 - 1745 ( 2007 ) .
`FMC BioPolymer of Avicel PH Production Instruction , 21 pages
`( 2005 ) .
`Fonteles “ Natruiretic and kalliuretic activities of guanylin and
`uroguanylin in isolated perfused rat kidney Am . J . Physiol . Renal
`Physiol . 275 : 191 - 197 ( 1998 ) .
`Forte , “ Guanylin regulatory peptides : structures , biological activi
`ties mediated by cyclic GMP and pathobiology , ” Regul . Pept . ,
`81 . 1 - 3 : 25 - 39 ( 1999 ) .
`Forte , Jr . , “ Uroguanylin and guanylin peptides : pharmacology and
`experimental therapeutics , ” Pharmacol . Ther . 104 ( 2 ) : 137 - 162
`( 2004 ) .
`Galt et al . , “ In Vivo Evaluation of an 111 In - Labeled ST - Peptide
`Analog for Specific - Targeting of Human Colon Cancers . " Nuc .
`Med . Biol . , 28 . 8 : 903 - 909 ( 2001 ) .
`Garcia “ Processing and characterization of human proguanylin
`expressed in Escherichia coli . ” J . Biol . Chem . 268 : 22397 - 22401
`( 1993 ) .
`Genbank 1 UYAA Chain A , Solution Structure A - Form
`uroguanylin . Mar . 15 , 2010 . 2 pages .
`Genbank 1UYBA — Chain A , Solution Structure B - Form
`uroguanylin . Mar . 15 , 2010 . 2 pages .
`Genbank AAB18760 . 1 ( rat , 1995 ) Mar . 11 , 2010 . 2 pages .
`
`Genbank AAB30324 . 1 Guca2B ( human , 1994 ) Mar . 11 , 2010 . 2
`pages .
`Genbank AAC50416 . 1 ; GUCA2B ( human , 1994 ) Mar . 11 , 2010 . 2
`pages .
`Genbank : AAD09215 . 1 ( mouse , 1996 ) Mar . 11 , 2010 . 2 pages .
`Genbank : CAA98994 . 1 ( guinea pig , 1996 ) Mar . 11 , 2010 . 2 pages .
`Genbank : CAB0642 . 1 ( pig , 1996 ) Mar . 11 , 2010 . 2 pages .
`Genbank : PRF . 738946 ( opossum , 1993 ) Mar . 15 , 2010 . 1 page .
`Greenberg “ Comparison of effects of uroguanylin , guanylin , and
`Escherichia coli heat - stable enterotoxin Sta in mouse intestine and
`kidney : evidence that uroguanylin is an intestinal natruiretic hor
`mone ” J . Invest . Med . 45 ( 5 ) : 276 - 282 ( 1997 ) .
`Guba et al . , “ Guanylin Strongly Stimulates Rat Duodenal HCO3
`Secretion : Proposed Mechanism and Comparison With Other
`Secretagogues . ” Gastroenterology , 111 . 6 : 1558 - 1568 ( 1996 ) .
`Gulcan “ Increased frequency of prediabetes in patients with irritable
`bowel syndrome ” Am . J . Med . Sci 338 : 116 - 119 ( 2009 ) .
`Gulcan The predictive value of CRP levels on future severe renal
`disease in overweight and obese subjects without diabetes mellitus
`and hypertension . Am . J . Med . Sci 334 : 444 - 451 ( 2007 ) .
`Gura , “ Systems for Identifying New Drugs Are Often Faulty , "
`Science 278 : 1041 - 1042 ( 1997 ) .
`Hamman et al . , “ Oral Delivery of Peptide Drugs . ” Biodrugs , 19 . 3 :
`165 - 177 ( 2005 ) .
`Hamra et al . , “ Uroguanylin : Structure and Activity of a Second
`Endogenous Peptide That Stimulates Intestinal Guanylate Cyclase . ”
`PNAS , 90 . 22 : 10464 - 10468 ( 1993 ) .
`Harris et al . , “ Drug Evaluation : Linaclotide , a New Direction in the
`Treatment of Irritable Bowel Syndrome and Chronic Constipation . ”
`Curr . Opin . Mol . Ther . , 9 . 4 : 403 - 410 ( 2007 ) .
`Hess , “ Gcap - II : isolation and characterization of the circulating
`form of human uroguanylin , ” FEBS Letters 374 : 34 - 38 ( 1995 ) .
`Hidaka “ Dual Function of the Propeptide of Prouroguanylin in the
`Folding of the Mature Peptide ” J . Biol . Chem . 275 : 25155 - 25162
`( 2000 ) .
`Hidaka “ In Vitro Disulfide - Coupled Folding of Guanylyl Cyclase
`Activating Peptide and Its Precursor Protein ” Biochem . 37 : 8498
`8507 ( 1998 ) .
`Hill , “ Analysis of the human guanylin gene and the processing and
`cellular localization of the peptide ” Proc . Natl . Acad . Sci USA
`92 : 2046 - 2050 ( 1995 ) .
`Hill et al . , " A New Human Guanylate Cyclase - Activating Peptide
`( Gcap - II , Uroguanylin ) : Precursor cDNA and Colonic Expression . "
`Biochim . Biophys . Acta . , 1253 : 146 - 149 ( 1995 ) .
`Hinds “ Synthesis and Characterization of Poly ( ethylene glycol )
`Insulin Conjugates " Bioconjug . Chem . 11 : 195 - 201 ( 2000 ) .
`Howard " Obesity and dyslipidemia ” Endocrinol . Metab . Clin . N .
`Am . 32 : 855 - 867 ( 2003 ) .
`http : / / www . merckmanuals . com / home / childrens _ health _ issues /
`hereditary _ metabolic disorders / disorders _ of Lipid _ metabolism .
`html : last updated 2009 ; last visited Sep . 25 , 2012 ( 1 page ) .
`http : www . nlm . nih . gov / medlineplus / obesity . html : 1999 - 2011 ; last
`visited Sep . 25 , 2012 ( 6 pages ) .
`Hudson “ Rethinking cystic fibrosis pathology : the critical role of
`abnormal reduced glutathione ( GSH ) transport caused by CFTR
`mutation ” Free Rad . Biol . Med . 30 : 1441 - 1461 ( 2001 ) .
`Huff , “ Inhibition of the Apical Sodium - Dependent Bile Acid
`Transporter Reduces LDL Cholesterol and ApoB by Enhanced
`Plasma Clearance of LDL ApoB , ” Arterioscler . Thromb . Vasc . Biol
`22 : 1884 - 1891 ( 2002 ) .
`Hughes “ Intracellular K + suppresses the activation of apoptosis in
`lymphocytes " J . Biol . Chem 272 ( 48 ) : 30567 - 30576 ( 1997 ) .
`Hui , “ Developmental and Physiological Regulation of Intestinal
`Lipid Absorption . III . Intestinal transporters and cholesterol absorp
`tion , " Am . J . Physiol . Gastrointest . Liver Physiol . 294 : G839 - 6843
`( 2008 ) .
`International Preliminary Report on Patentability , PCT Appl . No .
`PCT / US2011 / 051805 , 17 pages ( dated Dec . 15 , 2012 ) .
`International Preliminary Report on Patentability , PCT Appl . No .
`PCT / US2013 / 030551 , 7 pages ( dated Sep . 16 , 2014 ) .
`International Search Report in International Application No . PCT /
`US2009 / 046287 , 5 pages ( dated Nov . 10 , 2009 ) .
`
`

`

`US 9 , 925 , 231 B2
`Page 4
`
`( 56 )
`
`References Cited
`OTHER PUBLICATIONS
`International Search Report in International Application No . PCT /
`US2009 / 046288 , 9 pages ( dated Dec . 9 , 2009 ) .
`International Search Report , PCT Appl . No . PCT / US2011 / 051805 ,
`6 pages ( dated Jun . 21 , 2012 ) .
`International Search Report , PCT Appl . No . PCT / US2013 / 030551 ,
`5 pages ( dated Jun . 18 , 2013 ) .
`Joo et al . , “ Regulation of Intestinal C1 and HCO3 Secretion by
`Uroguanylin . ” Am . J . Physio . , 274 . 4 : G633G644 ( 1998 ) .
`Kelland “ Of mice and men ' : values and liabilities of the athymic
`nude mouse model in anticancer drug development ” Eur . J . Cancer
`40 ( 6 ) : 827 - 836 ( 2004 ) .
`Kita : Characterization of human uroguanylin : A member of the
`guanylin peptide family Am . J . Physiol . 266 : F342 - 8 ( 1994 ) .
`Klodt , “ Synthesis , biological activity and isomerism of guanylate
`cyclase C - activating peptides guanylin and uroguanylin , " J . Pep .
`Res . 50 ( 2 ) : 222 - 230 ( 1997 ) .
`Krause “ The guanylin and uroguanylin peptide hormones and their
`receptors ” Acta Anat . 160 : 213 - 231 ( 1997 ) .
`Lam “ Serotonin and energy balance : molecular mechanisms and
`implications for type 2 diabetes " Expert Rev . Mol . Med . 9 : 1 - 24
`( 2007 ) .
`Leister “ Human colorectal cancer : High frequency of deletions at
`chromosome 1p35 ” Can . Res . 50 : 7232 - 7235 ( 1990 ) .
`Li “ Purification , cDNA sequence and tissue distribution of rat
`uroguanylin ” Reg . Pep . 68 : 45 - 56 ( 1997 ) .
`Li and Chiang , “ Bile Acid Signaling in Liver Metabolism and
`Diseases ” , Journal of Lipids , Hindawi Publishing Corporation ,
`2012 : 1 - 9 , Article ID 754067 ( 2011 ) .
`Lipkin “ Gastric cell regeneration ” Arch . Fr . Mal . Appl . Dig . ( Paris )
`61 ( 10 - 11 ) : 691 - 693 ( 1972 ) .
`Lorenz “ Uroguanylin knockout mice have increased blood pressure
`and impaired natriuretic response to enteral NaCl load " J . Clin .
`Invest . 112 ( 8 ) : 1244 - 1254 ( 2003 ) .
`MacFarlane and MacFarlane , “ Factors affecting fermentation reac
`tions in the large bowel , ” Proc . Nutr . Soc . 52 ( 2 ) : 367 - 373 ( 1993 ) .
`Magert Porcine guanylin and uroguanylin : cDNA sequences ,
`deduced amino acid sequences , and biological activity of the
`chemically synthesized peptides ' Biochem . Biophys . Res . Comm .
`259 : 141 - 148 ( 1999 ) .
`Mahato et al . , “ Emerging Trends in Oral Delivery of Peptide and
`Protein Drugs . ” Crit . Rev . Therapeutic Drug Carrier Sys . , 20 . 2 - 3 :
`153 - 214 ( 2003 ) .
`Marx et al . , “ One Peptide , Two Topologies : Structure and
`Interconversion Dynamics of Human Uroguanylin Isomers . ”
`J .
`Pept . Res . , 52 : 229 - 240 ( 1998 ) .
`Mihranyan et al . , “ Moisture sorption by cellulose powders of
`varying crystallinity ” , International Journal of Pharmaceutics ,
`269 ( 2 ) : 433 - 442 ( 2004 ) .
`Miyazato “ Uroguanylin gene expression in the alimentary tract and
`extra - gastrointestinal tissues ” FEBS Letters , 398 : 170 - 174 ( 1996 ) .
`Miyazato " Cloning and characterization of a cDNA encoding a
`precursor for human uroguanylin ” Biochem Biophys Res . Comm .
`219 : 644 - 648 ( 1996 ) .
`Moon “ Effects of age , ambient temperature , and heat - stable
`Escherichia coli enterotoxin of intestinal transit in infant mice "
`Infect . Immun . 25 ( 1 ) : 127 - 132 ( 1979 ) .
`Muller - Lissner “ Safety , tolerability , and efficacy of tegaserod over
`13 months in
`patients with chronic constipation ” Am . J .
`Gastroenterol . 101 : 2558 - 2569 ( 2006 ) .
`Nakazato “ Tissue distribution , cellular source , and structural analy
`sis of rat immunoreactive uroguanylin ” Endocrinol . 139 : 5247 - 5254
`( 1998 ) .
`Nathan “ Copolymers of lysine and polyethylene glycol : a new
`family of functionalized drug carriers ” Bioconjug Chem . 4 ( 1 ) : 54 - 62
`( 1993 ) .
`Nemethy “ Energy parameters in polypeptides . 9 . Updating of geo
`metrical parameters non - bonded interactions , and hydrogen bond
`interactions for the naturally occurring amino acids ” J . Phys . Chem .
`87 : 1883 - 1887 ( 1983 ) .
`
`Nikiforovich " Computation molecular modeling in peptide design ”
`Int . J . Pep . Prot . Res . 44 : 513 - 531 ( 1994 ) .
`Nikiforovich “ Topographical requirements for 6 - selective opioid
`peptides ” Biopolymers , 31 : 942 - 955 ( 1991 ) .
`Nyburg " Some uses of best molecular fit routine ” Acta Crystal
`lographica B30 ( Part 1 ) : 251 - 253 ( 1974 ) .
`Ohbayashi , “ Effects of uroguanylin and guanylin against antigen
`induced bronchoconstriction and airway microvascular leakage in
`sensitized guinea - pigs ” Life Sci . , 62 ( 20 : 1883 - 1844 ( 1998 ) .
`Perkins “ Uroguanylin is expressed by enterochromaffin cells in the
`rat gastrointestinal tract " Gastroenterol 113 : 1007 - 1014 ( 1997 ) .
`Peterson " Integrating pharmacology and in vivo cancer models in
`preclinical and clinical drug development ” Eur . J . Cancer 40 : 837
`844 ( 2004 ) .
`Pitari “ Guanylyl cyclase C agonists regulate progression through
`the cell cycle of human colon carcinoma cells ” , Proc . Natl . Acad .
`Sci . USA 98 ( 14 ) : 7546 - 7851 ( 2001 ) .
`Potten “ Regulation and significance of apoptosis in the stem cells of
`the gastrointestinal epithelium ” Stem Cells 15 : 82 - 93 ( 2001 ) .
`Provenzale “ Surveillance issues in inflammatory bowel disease :
`ulcerative colitis ” J . Clin . Gastroenterol 32 : 99 - 105 ( 2001 ) .
`PubChem , CID 469 , http : / / pubchem . ncbi . nlm . nih . gov / summary /
`summary . cgi ? cid = 469 # x27 , ( last visited Oct . 18 , 2014 ) . 19 pages .
`Ramamoorthy “ Phosphorylation of threonine residue 276 is
`required for acute regulation of serotonin transporter by cyclic
`GMP ” J . Biol . Chem . 282 ( 16 ) : 11639 - 11647 ( 2007 ) .
`Reddy and Rao “ Lipid metabolism and liver inflammation II fatty
`liver disease and fatty acid oxidation ” Am . J . Physiol . Gastrointest .
`Liver Physiol . 290 : 6852 - 6858 ( 2006 ) .
`Remington , JP “ Remington ' s Pharmaceutical Sciences " Mack Pub .
`Co . 16th edition ( 1980 ) 7 pages .
`Roberts " Chemistry of peptide and protein PEGylation ” Adv . Drug .
`Deliv . Rev . 54 : 459 - 476 ( 2002 ) .
`Rolfe and Milla , “ Nitric oxide stimulates cyclic guanosine
`monophosphate production and electrogenic secretion in Caco - 2
`colonocytes , " Clin . Sci . ( Lond ) . 96 ( 2 ) : 165 - 170 ( 1999 ) .
`Samuel “ Absorption of bile acids from the large bowel in man ” J .
`Clin . Invest . 47 : 2070 - 2978 ( 1968 ) .
`Schulz et al . , “ Guanylyl Cyclase is a Heat - Stable Enterotoxin
`Receptor . ” Cell , 63 . 5 : 941 - 948 ( 1990 ) .
`Schulz et al . , “ Side Chain Contributions to the Interconversion of
`the Topological Isomers of Guanylin - Like Peptides . ” J . Peptide Sci . ,
`11 . 6 : 319 - 330 ( 2005 ) .
`Sciaky “ Mapping of guanylin to murine chromosome 4 and human
`chromosome 1p34p35 " Genomics 26 : 427 - 429 ( 1995 ) .
`Sellers “ heat - stable enterotoxin of Escherichia coli stimulates a
`non - CFTR - mediated duodenal bicarbonate secretory pathway " Am
`J . Physiol . Gastrointest . Liver Physiol . 288 : G654 - G663 ( 2005 ) .
`Shailubhai “ Gaunilib , an antagonist of guanylate C , is a new class
`of oral drug candidate that ameliorates inflammation in models of
`experimental colitis ” [ Abstract ] : In Charon ' s and colitis foundation
`of America ( 2007 ) 1 page .
`Shailubhai “ Guanilib , an agonist of Guanylate C , is a new class of
`oral drug candidate for GI disorders and colon cancer ” [ abstract ] in
`GTCbio , 2008 . 1 page .
`Shailubhai “ Guanylate cyclase - C agonists as a new class of drug
`candidates for GI motility and inflammatory bowel disease "
`[ Abstract ] 2009 ( 1 page ) .
`Shailubhai “ Guanylin Peptides : New class of oral drug candidates ”
`[ Abstract ] : In World Congress 2008 ( 2 pages ) .
`Shailubhai “ Inflammatory bowel disease ” Feb . 2008 : S5 2007 IBD
`Abstract : Oral Presentation ( 1 page ) .
`Shailubhai “ Phase II Clinical Evaluation of SP - 304 , a Guanylate
`Cyclase - C Agonist , for Treatment of Chronic Constipation , " Am . J .
`Gastroenterol . 105 ( Suppl . 1 ) : 3487 - 5488 ( 2010 ) .
`Shailubhai " SP - 304 to treat GI disorders effects of a single , oral
`dose of SP - 304 in safety , tolerability , pharmacokinetics and
`pharmacodynamics in healthy volunteers ” [ Abstract ] : in Digestive
`Disease Week , ( 2009 ) 1 page .
`Shailubhai “ Therapeutic applications of guanylate cyclase - c recep
`tor agonists ” Curr . Opin . Drug Disc . Devel . 5 ( 2 ) : 261 - 268 ( 2002 ) .
`
`

`

`US 9 , 925 , 231 B2
`Page 5
`
`( 56 )
`
`References Cited
`OTHER PUBLICATIONS
`Shailubhai et al . , “ Uroguanylin Treatment Suppresses Polyp For
`mation in the ApcMin / + Mouse and Induces Apoptosis in Human
`Colon Adenocarcinoma Cells via Cyclic GMP . ” Cancer Res . , 60 :
`5151 - 5157 ( 2000 ) .
`Shinozaki “ High proliferative activity is associated with dysplasia
`in ulcerative colitis ” Dis . Colon Rectum 43 : S34 - S39 ( 2000 ) .
`Sindice “ Guanylin , Uroguanylin , and Heat - stable Enterotoxin Acti
`vate Guanylate Cyclase C and / or a Pertussis Toxin - sensitive G
`Protein in Human Proximal Tubule Cells ” . J . Biol . Chem .
`277 : 17758 - 17764 ( 2002 ) .
`Spranger “ Inflammatory cytokines and the risk to develop Type 2
`Diabetes : Results of the prospective population - based European
`prospective investigation into cancer and nutrition ( EPIC ) - Potsdam
`study " Diabetes , 52 : 812 - 817 ( 2003 ) .
`St . John ' s Providence Health Center ; Preventing Obesity ,
`http : www . stjohnprovidence . org / healthInfoLib / swArticle . aspx ? 85 .
`P07863 ; last visited Sep . 25 , 2012 ( 2 pages ) .
`Takada , “ Alteration of a Single Amino Acid in Peroxisome
`Proliferator - Activated Receptor - a ( PPAR? ) Generates a PPARd
`Phenotype ” Mol . Endocrinol . 14 ( 5 ) : 733 - 740 ( 2000 ) .
`Talley “ Medical costs in community subjects with irritable bowel
`syndrome ” Gastroenterol . 109 : 17361741 ( 1995 ) .
`Thomas , “ Cholesterol dependent downregulation of mouse and
`human apical sodium dependent bile acid transporter ( ASBT ) gene
`expression : molecular mechanism and physiological conse
`quences , ” GUT 55 : 1321 - 1331 ( 2006 ) .
`Tian “ STa peptide analogs for probing guanylyl cyclase C . ”
`Biopolymers ( Pept . Sci ) . 90 ( 5 ) : 713 - 723 ( 2008 ) .
`Tilg “ Inflammatory mechanisms in the regulation of insulin resis
`tance ” Mol . Med . 14 : 222 - 231 ( 2008 ) .
`Vaandrager , “ Structure and Function of the Heat - Stable Enterotoxin
`Receptor / Guanylyl Cyclase C . ” Mal . Cell . Biochem . , 230 . 1 - 2 :
`73 - 83 ( 2002 ) .
`Variyam , “ Luminal bacteria and proteases together decrease adher
`ence of Entamoeba histolytica trophozoites to Chinese hamster
`
`ovary epithelial cells : A novel host defense against an enteric
`pathogen , ” GUT 39 ( 4 ) : 521 - 527 ( 1996 ) .
`Venkatakrishnan Exaggerated activation of nuclear factor - B and
`altered I B - processing in cystic fibrosis bronchial epithelial cells .
`Am . J . Resp . Cell Mol . Biol . 23 ( 3 ) : 396 - 403 ( 2000 ) .
`Veronese “ Bioconjugation in pharmaceutical chemistry ” Farmaco ,
`54 : 497 - 516 ( 1999 ) .
`Veronese “ PEGylation , successful approach to drug delivery ” Drug .
`Disc . Today . 10 ( 21 ) : 1451 - 1458 ( 2005 ) .
`Veronese “ Peptide and protein PEGylation : a review of problems
`and solutions ” Biomaterial , 22 : 405 - 417 ( 2001 ) .
`Waldman " Heterogeneity of guanylyl cylcase C expressed by
`human colorectal cancer cell lines in vitro ” Can . Epidemiol .
`Biomarkers & Prevention 7 : 505 - 514 ( 1998 ) .
`Weber “ Activation of NF - kB in airway epithelial cells is dependent
`on CFTR trafficking and CI channel function ” Am . J . Physiol . Lung
`Cell Mol . Biol . 281 ( 1 ) : L71 - 78 ( 2001 ) .
`Welsh “ Molecular mechanisms of CFTR chloride channel dysfunc
`tion in cystic fibrosis ” Cell 73 : 1251 - 1254 ( 1993 ) .
`Whitaker “ The uroguanulin gene ( Bucalb ) is linked to guanylin
`( Guca2 ) on mouse chromosome 4 ” Genomics 45 : 348 - 354 ( 2002 ) .
`Wong " Cell proliferation in gastrointestinal mucosa ” J . Clin . Pathol .
`52 : 321 - 333 ( 1999 ) .
`Wong “ Histogenesis of human colorectal adenomas and
`hyperplastic polyps : the role of cell proliferation and crypt fission ”
`GUT 50 : 212 - 217 ( 2002 ) .
`Written Opinion of the International Searching Authority , PCT
`Appl . No . PCT / US2011 / 051805 , 5 pages ( dat

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket